BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,080 filers reported holding BAXTER INTL INC in Q3 2020. The put-call ratio across all filers is 1.00 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $614 | -18.6% | 16,282 | -1.6% | 0.01% | -18.2% |
| Q2 2023 | $754 | +10.7% | 16,550 | -1.4% | 0.01% | +10.0% |
| Q1 2023 | $681 | -30.3% | 16,790 | -12.4% | 0.01% | -28.6% |
| Q4 2022 | $977 | -100.0% | 19,164 | -90.1% | 0.01% | -92.4% |
| Q3 2022 | $10,397,000 | -17.5% | 193,031 | -1.6% | 0.18% | -15.2% |
| Q2 2022 | $12,595,000 | -14.7% | 196,092 | +3.0% | 0.22% | -1.4% |
| Q1 2022 | $14,758,000 | -5.0% | 190,328 | +5.2% | 0.22% | -19.1% |
| Q4 2021 | $15,536,000 | -8.7% | 180,993 | -14.4% | 0.27% | -16.6% |
| Q3 2021 | $17,008,000 | -0.7% | 211,458 | -0.6% | 0.33% | -4.1% |
| Q2 2021 | $17,124,000 | -13.5% | 212,716 | -9.4% | 0.34% | -18.3% |
| Q1 2021 | $19,795,000 | +1.5% | 234,708 | -3.5% | 0.42% | -7.6% |
| Q4 2020 | $19,510,000 | -0.6% | 243,147 | -0.4% | 0.45% | -11.9% |
| Q3 2020 | $19,627,000 | -7.4% | 244,060 | -0.9% | 0.51% | -16.8% |
| Q2 2020 | $21,198,000 | +10.6% | 246,207 | +4.3% | 0.61% | -1.4% |
| Q1 2020 | $19,173,000 | -5.0% | 236,147 | -2.2% | 0.62% | +22.4% |
| Q4 2019 | $20,186,000 | +19.2% | 241,403 | +24.6% | 0.51% | -5.6% |
| Q3 2019 | $16,941,000 | +10.2% | 193,679 | +3.2% | 0.54% | +10.7% |
| Q2 2019 | $15,376,000 | +0.8% | 187,737 | +0.0% | 0.49% | -23.9% |
| Q1 2019 | $15,261,000 | +32.4% | 187,688 | +7.2% | 0.64% | +14.7% |
| Q4 2018 | $11,523,000 | +4.2% | 175,068 | +22.1% | 0.56% | +1.1% |
| Q3 2018 | $11,054,000 | +4.6% | 143,390 | +0.2% | 0.55% | +0.2% |
| Q2 2018 | $10,566,000 | +15.9% | 143,093 | +2.1% | 0.55% | +11.1% |
| Q1 2018 | $9,117,000 | +28.0% | 140,179 | +27.2% | 0.50% | +11.2% |
| Q4 2017 | $7,123,000 | +2.3% | 110,203 | -0.7% | 0.45% | -6.3% |
| Q3 2017 | $6,966,000 | +24778.6% | 111,012 | +12914.3% | 0.48% | +15766.7% |
| Q3 2015 | $28,000 | +600.0% | 853 | +1450.9% | 0.00% | – |
| Q2 2015 | $4,000 | -89.2% | 55 | -89.7% | 0.00% | -100.0% |
| Q1 2015 | $37,000 | -62.2% | 536 | -59.8% | 0.00% | -60.0% |
| Q4 2014 | $98,000 | -20.3% | 1,332 | -22.1% | 0.01% | -28.6% |
| Q3 2014 | $123,000 | -1.6% | 1,709 | -1.0% | 0.01% | -17.6% |
| Q2 2014 | $125,000 | +8.7% | 1,727 | +10.1% | 0.02% | +6.2% |
| Q1 2014 | $115,000 | – | 1,568 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SECTOR GAMMA AS | 713,500 | $49,895,000 | 12.74% |
| Veritas Asset Management LLP | 7,636,450 | $534,017,000 | 7.53% |
| FIRST NEW YORK SECURITIES LLC /NY | 154,158 | $10,780,269,000 | 5.40% |
| Gabalex Capital Management LLC | 200,000 | $14,981,000 | 5.39% |
| Veritas Investment Management LLP | 291,825 | $18,816,000 | 5.32% |
| Tweedy, Browne Co LLC | 2,543,966 | $177,900,000 | 4.91% |
| York Capital Management Global Advisors, LLC | 8,074,375 | $564,641,000 | 4.78% |
| First Fiduciary Investment Counsel, Inc. | 270,675 | $18,928,000 | 4.10% |
| SCHARF INVESTMENTS, LLC | 2,247,225 | $157,148,000 | 4.03% |
| Osher Van de Voorde Investment Management | 96,235 | $6,730,000 | 3.91% |